Blood biomarkers reveal subtle midlife cognitive decline tied to Alzheimer's risk

For the first time, researchers found blood biomarkers for Alzheimer's disease that correlated with minor cognitive differences in midlife adults who did not have dementia. The study, led by UC San Francisco, also found that the biomarkers, which measure tau and amyloid plaque, were associated with a greater chance of cognitive decline in these participants.